Table 18-3.
Drugs and endocrine disease
Drug* Effect
Drugs inducing endocrine disease
Chlorpromazine Increase prolactin, causing galactorrhoea
Metoclopramide (and all dopamine antagonists)
Oestrogens
Iodine Hyperthyroidism
Amiodarone
Lithium Hypothyroidism
Amiodarone
Chlorpropamide Inappropriate ADH secretion
Ketoconazole Hypoadrenalism
Metyrapone, aminoglutethimide
Chemotherapy Ovarian and testicular failure
Drugs simulating endocrine disease
Sympathomimetics Mimic thyrotoxicosis or phaeochromocytoma
Amfetamines
Liquorice Increase mineralocorticoid activity; mimic aldosteronism
Carbenoxolone
Purgatives Hypokalaemia
Diuretics Secondary aldosteronism
ACE inhibitors Hypoaldosteronism
Drugs affecting hormone-binding proteins
Anticonvulsants Bind to TBG – decrease total T4
Oestrogens Raise TBG and CBG – increase total T4/cortisol
Exogenous hormones or stimulating agents
Use, abuse or misuse, by patient or doctor, of the following:
Steroids Cushing’s syndrome
  Diabetes
Thyroxine Thyrotoxicosis factitia
Vitamin D preparations Hypercalcaemia
Milk and alkali preparations
Insulin Hypoglycaemia
Sulphonylureas

A detailed history including the past, family and social history is essential for making the diagnosis, planning appropriate management and interpreting results of borderline hormonal blood tests. The past history should include previous surgery or radiation involving endocrine glands, menstrual history, pregnancy and growth in childhood. A full drug history is mandatory as endocrine problems are quite often iatrogenic (Table 18.3). Family history of autoimmune disease, endocrine disease including tumours, diabetes and cardiovascular disease is frequently relevant, and knowledge of family members’ height, weight, body habitus, hair growth and age of sexual development may aid interpretation of the patient’s own symptoms.

Physical signs are listed under the relevant systems.

No Comments »

No comments yet.

RSS feed for comments on this post. TrackBack URL

Leave a comment